$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
How long does it take for Geftinat to take effect?
2025-10-19 11:44:20
Check Details
How many boxes of Geftinat should be taken in one course of treatment?
2025-10-19 11:44:20
Check Details
What should Geftinat pay attention to?
2025-10-19 11:44:20
Check Details
Where can I buy Geftinat?
2025-10-19 11:44:20
Check Details
How effective is Geftinat?
2025-10-19 11:44:20
Check Details
How to buy Geftinat?
2025-10-19 11:44:20
Check Details
How long does it take to stop taking Geftinat?
2025-10-19 11:44:20
Check Details
[11C] Osimertinib can reduce brain metastasis of EGFR+ NSCLC
2025-10-19 11:44:20
Check Details
HIC testing helps predict response to immunotherapy in NSCLC patients_Cornhule
2025-10-19 11:44:20
Check Details
How about Serpatinib from Eli Lilly and Company?
2025-10-19 11:44:20
Check Details
How effective is Eli Lilly’s anticancer drug Serpatinib in its anticancer effect?
2025-10-19 11:44:20
Check Details
How effective is Eli Lilly's Retevmo in treating lung cancer?
2025-10-19 11:44:20
Check Details
1
2
...
3812
3813
3814
3815
3816
3817
3818
...
4163
4164
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sotorasib (Lumakras): Indications, Dosing, Safety and the Next-Gen KRAS G12C Landscape
2
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
3
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
4
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
5
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
6
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
7
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
8
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
9
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
10
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
11
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
12
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes